Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/10/2001EP1139996A1 Deodorizing cosmetic agents
10/10/2001EP1139994A1 Oral hygiene product containing spherical microparticles on the basis of linear water-insoluble polyglucans
10/10/2001EP1139980A1 Cosmetic or medical preparation for topical use
10/10/2001EP1139974A1 Soy depigmenting and skin care compositions
10/10/2001EP1139972A1 Dihydropyrimidines and uses thereof
10/10/2001EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
10/10/2001EP1139793A2 Inhibitors of the bitter taste response
10/10/2001EP1139789A1 Alpha-amylase-resistant starch for producing foodstuff and medicaments
10/10/2001EP1139781A1 Food or veterinary composition for domestic carnivores containing free tyrosine
10/10/2001EP1139755A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
10/10/2001EP1139754A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
10/10/2001EP1139753A1 Formulations for treating disease and methods of using same
10/10/2001EP1139752A1 Methods and compositions for treatment of cell proliferative disorders
10/10/2001EP1139751A1 Efficient and stable $i(in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
10/10/2001EP1139750A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
10/10/2001EP1139746A1 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
10/10/2001EP1139744A1 Exo-r-mecamylamine formulation and use in treatment
10/10/2001EP1139743A1 Exo-s-mecamylamine formulation and use in treatment
10/10/2001EP1100512A4 Preparation of thioarabinofuranosyl compounds and use thereof
10/10/2001EP1083172A4 N-substituted derivatives of 5-oxyiminobarbituric acid
10/10/2001EP1051170B1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
10/10/2001EP0923566A4 High molecular weight polymer-based prodrugs
10/10/2001EP0922044B1 Pyrrolo(3,2-c) quinoline derivatives
10/10/2001EP0840731B1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists
10/10/2001EP0840620B1 Il-8 antagonists for treatment of asthma
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0793476B1 Use of Mangiferin or Derivatives thereof for Cosmetic Applications
10/10/2001EP0770071B1 Sulfonamide derivatives of azolones anti-helicobacter agents
10/10/2001EP0765320B1 Benzimidazolone derivatives with central dopaminergic activity
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001EP0724582B1 Preparation of omeprazole and lansoprazole and intermediates useful therein
10/10/2001CN1317008A Novel antibacterial compounds
10/10/2001CN1317006A Antiparasitic artemisinin derivatives (endoperoxides)
10/10/2001CN1317005A Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
10/10/2001CN1316998A Thiobenzimidazole derivatives
10/10/2001CN1316997A Tripterygium wilfordii lactone prodrugs having high aqueous solubility
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316994A Piperidine derivatives
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316992A Process for preparation of zofenopril calcium salt
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316911A Compositions comprising sympathomimetic amine salts unsuitable for illegal use
10/10/2001CN1316904A Treatment of persistent pain
10/10/2001CN1316903A Compositions and methods for treating and preventing bone diseases using tocotrienols
10/10/2001CN1316902A Therapeutic compositions (II)
10/10/2001CN1316901A The use of fumaric acid derivatives in transplant medicine
10/10/2001CN1316898A Oral micro-emulsion composition of silybin
10/10/2001CN1316429A Method for preparing ilotycin derivative
10/10/2001CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative
10/10/2001CN1316279A X-ray magnetic therapy machine for PDT therapy of cancer by combining radiatherapy with chemicotherapy and its medicine
10/10/2001CN1316261A Chinese-medical buccal lozenge and its preparing process
10/10/2001CN1316247A Clamycin injection and its preparing process
10/10/2001CN1316246A Application of tea polyphenol in treating thyroid disease
10/10/2001CN1316245A Application of tea polyphenol and its oxide in treating muscular disease
10/10/2001CN1316244A Application of tea polyphenol in treating kidney disease
10/10/2001CN1316243A Application of tea polyphenol and its oxide in treating anemia
10/10/2001CN1072679C Azasteroid compound, preparation and its use
10/10/2001CN1072670C Trans-apovincaminic acid ester derivatives as drugs
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/10/2001CN1072668C Dihydrobenzofuran and related compounds useful and anti-inflammatory agents
10/10/2001CN1072667C Mercaptoalkylpeptidyl compounds having imidzole substituent and their use as inhibitors of matrix metalluproteinass (MMP) and/or tumour necrosis factor (TNF)
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/10/2001CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines
10/10/2001CN1072660C 2,1,3-benzothia (oxa) diazole derivatives having endothelin receptor antagonistic effect
10/10/2001CN1072655C New Heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical composition containing their
10/10/2001CN1072654C Benzamide derivative, composition containing said derivative and use thereof
10/10/2001CN1072650C Bibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agent
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/10/2001CN1072646C Stable vitamin A.
10/10/2001CN1072645C Novel 2,3,5-trimethyl-4-hydroxy radical-N-acid aniline derivatives and preparation method and use thereof
10/10/2001CN1072644C 4-fluoroalkyl substituted phenacyl guanidine, its prpearing method, application as medicine or diagnosis agent and medicine containing such compound
10/10/2001CN1072504C 肽的应用 Application peptide
10/10/2001CN1072502C Medicine for treating angitis
10/10/2001CN1072500C Medicine for treatment of arthritis and its preparing process
10/10/2001CN1072499C External-use medicine for curing body surface chronic ulcers
10/10/2001CN1072498C External-use medicine for treating burn and scald of humanbody
10/10/2001CN1072493C Compound asthma capsule and its preparation method
10/10/2001CN1072486C Medicament for giving up narcotic drugs and stopping pain and its preparation method
10/10/2001CN1072485C Use of fumagillo and derivatives thereof for preparing medicaments against intestinal infections
10/10/2001CN1072484C Method for making tablet and granulate containing sodium 2-mercaptoethanesulfonate
10/10/2001CN1072483C Stable, ingestabl and absorbadle NADH and NADPH therapeutic compositions
10/10/2001CN1072482C Low-molecular heparin liposome spray preparation and its preparation technology
10/10/2001CA2343426A1 Compound, specificially for cosmetic use, containing a steroid and a 2-alkyl acanol or an ester
10/10/2001CA2343344A1 Erythromycin a derivatives
10/09/2001US6300504 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates
10/09/2001US6300499 α1-adrenergic receptor antagonists
10/09/2001US6300491 Antisense nucleotide for the treatment of allograft defects, cancers and metastasis, inflammatory bowel disease, psoriasis and skin disorders
10/09/2001US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers
10/09/2001US6300442 Heating vinyl monomer with oil as solvent to polymerize, also containing free radical catalyst and optional crosslinker, agitaing under inert gas, adding water to form emulsion
10/09/2001US6300377 Coenzyme Q products exhibiting high dissolution qualities
10/09/2001US6300376 Indane dimer compounds and their pharmaceutical use
10/09/2001US6300375 Administering sodium oxamate for prophylaxis or therapy of diabetes or complications due to diabetes
10/09/2001US6300374 Applying the medicament comprising zinc salt of conjugated linoleic acid to a skin disorder, wherein the skin disorder is skin cancer
10/09/2001US6300373 Antiproliferative and neurotrophic molecules
10/09/2001US6300372 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates
10/09/2001US6300369 Hydroxy-kojic acid skin peel
10/09/2001US6300367 Containing selective estrogen receptor modulator such as droloxifene and isofalvone comprising genstein used for therapy and phophylaxis breast cancer
10/09/2001US6300366 Aminopyrroline compounds
10/09/2001US6300365 Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
1 ... 5999 6000 6001 6002 6003 6004 6005 6006 6007 6008 6009 6010 6011 6012 6013 6014 6015 6016 6017 6018 6019 ... 7860